<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> (L-OHP)is an important chemotherapeutic drug for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0009830'>Peripheral neuropathy</z:hpo> was observed in 90% of patients who received L-OHP.<z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">Neuropathy</z:e> often results in the discontinuation of treatment or a decrease the quality of life(QOL) </plain></SENT>
<SENT sid="2" pm="."><plain>The most effective method for reducing <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> is the discontinuation of L-OHP </plain></SENT>
<SENT sid="3" pm="."><plain>To reduce <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, we administered Keishikajutsubutou(TJ-18)with powdered processed aconite root(TJ-3023), and we report the effect of these compounds </plain></SENT>
<SENT sid="4" pm="."><plain>The subjects comprised 11 patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>L-OHP(85mg/m2)was administered as part of the FOLFOX6(10 patients)or FOLFOX7(1 patient)regimen </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had experienced <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We administered TJ-18(7.5 g)and T-3023(1 g) </plain></SENT>
<SENT sid="8" pm="."><plain>After 2 weeks, the TJ-3023 dose was increased to 2 g for nonresponders </plain></SENT>
<SENT sid="9" pm="."><plain>The response was evaluated according to the Neurotoxicity Criteria of DEBIOPHARM </plain></SENT>
<SENT sid="10" pm="."><plain>Reduction in <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> was observed in 5 cases(45.5% ) </plain></SENT>
<SENT sid="11" pm="."><plain>Among 6 patients whose feet and hands felt warm, reduction in <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> was observed in 5(83.3% ) </plain></SENT>
</text></document>